Pearson
PSO
16.42
+0.10
+0.61%
Pearson
US · PSO
#1496 by market cap
Listed 1970
16.42
+0.10
+0.61%
Live - 5344 symbols - heartbeat 195s ago
· 2026-10-08 08:06
Pre-market
16.79
+2.25%
After-hours
16.42
0.00%
Overnight
16.38
-0.24%
- Market cap
- 9.87B
- P/E (TTM)i
- 24.84
- P/Bi
- 2.23
- EPSi
- 0.67
- Div yieldi
- 2.08%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on PSO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.33, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.70% YoY
Margins
- Gross margin
- 52.00%
- Operating margin
- 16.66%
- Net margin
- 9.37%
Key ratios & quality
- Enterprise valuei
- 10.60B
- PEG ratioi
- 2.17
- Altman Z-Scorei
- 3.33
PEG uses trailing P/E against the 3-year net income growth rate (11.45%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.13B | 3.87B | 3.40B | 3.43B | 3.84B | 3.67B | 3.55B | 3.58B |
| Gross profit | 2.19B | 2.01B | 1.63B | 1.68B | 1.80B | 1.84B | 1.81B | 1.86B |
| Selling & admin expenses | 1.89B | 1.70B | 1.45B | 1.39B | 1.45B | 1.36B | 1.31B | 1.30B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 373.00M | 362.00M | 228.00M | 333.00M | 396.00M | 513.00M | 544.00M | 596.00M |
| Pretax profit | 498.00M | 232.00M | 380.00M | 177.00M | 323.00M | 493.00M | 510.00M | 457.00M |
| Tax | -92.00M | -34.00M | 50.00M | -1.00M | 79.00M | 113.00M | 75.00M | 121.00M |
| Net profit | 590.00M | 266.00M | 330.00M | 178.00M | 244.00M | 380.00M | 435.00M | 336.00M |
| Basic EPS | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Diluted EPS | 0.76 | 0.34 | 0.44 | 0.23 | 0.33 | 0.53 | 0.64 | 0.51 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- | -- | -- |
| Pretax profit | -- | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- | -- | -- |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.38B | 3.17B | 3.34B | 3.22B | 2.82B | 2.43B | 2.73B | 2.32B |
| Cash & ST investments | 568.00M | 437.00M | 1.10B | 937.00M | 558.00M | 312.00M | 543.00M | 333.00M |
| Inventory | 164.00M | 169.00M | 129.00M | 98.00M | 105.00M | 91.00M | 74.00M | 66.00M |
| Total assets | 7.91B | 7.65B | 7.45B | 7.34B | 7.32B | 6.73B | 6.89B | 6.46B |
| Total current liabilities | 2.13B | 1.49B | 1.65B | 1.58B | 1.48B | 1.40B | 1.48B | 1.16B |
| Short-term debt | 46.00M | 92.00M | 254.00M | 155.00M | 86.00M | 67.00M | 315.00M | 62.00M |
| Long-term debt | 672.00M | 823.00M | 787.00M | 680.00M | 610.00M | 611.00M | 705.00M | 1.00B |
| Total liabilities | 3,380,000,000.00 | 3,327,000,000.00 | 3,317,000,000.00 | 3,063,000,000.00 | 2,909,000,000.00 | 2,739,000,000.00 | 2,839,000,000.00 | 2,795,000,000.00 |
| Total equity | 4.53B | 4.32B | 4.13B | 4.28B | 4.42B | 3.99B | 4.05B | 3.66B |
| Retained earnings | 1.04B | 911.00M | -- | 1.07B | 881.00M | 745.00M | 827.00M | 629.00M |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.43B | 2.52B | 2.73B | 2.34B | 2.32B | 2.28B |
| Cash & ST investments | 312.00M | 332.00M | 543.00M | 347.00M | 333.00M | 339.00M |
| Inventory | 91.00M | 89.00M | 74.00M | 71.00M | 66.00M | 72.00M |
| Total assets | 6.73B | 6.71B | 6.89B | 6.23B | 6.46B | 6.37B |
| Total current liabilities | 1.40B | 1.42B | 1.48B | 1.01B | 1.16B | 1.14B |
| Short-term debt | 67.00M | 313.00M | 315.00M | 62.00M | 62.00M | 70.00M |
| Long-term debt | 611.00M | 842.00M | 705.00M | 1.01B | 1.00B | 1.29B |
| Total liabilities | 2,739,000,000.00 | 2,898,000,000.00 | 2,839,000,000.00 | 2,620,000,000.00 | 2,795,000,000.00 | 3,014,000,000.00 |
| Total equity | 3.99B | 3.81B | 4.05B | 3.61B | 3.66B | 3.36B |
| Retained earnings | 745.00M | -- | 827.00M | 658.00M | 629.00M | 295.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 462.00M | 369.00M | 389.00M | 326.00M | 361.00M | 525.00M | 627.00M | 656.00M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | 262.00M | 176.00M | 255.00M | 150.00M | 214.00M | 399.00M | 503.00M | 522.00M |
| Dividends paid | -136.00M | -147.00M | -146.00M | -149.00M | -156.00M | -154.00M | -156.00M | -160.00M |
| Stock buybacks / issuance | -147.00M | -45.00M | -176.00M | -10.00M | -383.00M | -212.00M | -351.00M | -415.00M |
| Ending cash balance | 525.00M | 434.00M | 1.11B | 937.00M | 543.00M | 309.00M | 543.00M | 333.00M |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.79 | 5.98 | 7.35 | 3.79 | 5.58 | 9.03 | 10.83 | 8.72 |
| ROA %i | 7.45 | 3.39 | 4.11 | 2.15 | 3.30 | 5.38 | 6.37 | 5.02 |
| ROIC %i | 11.58 | 5.11 | 6.09 | 3.53 | 4.31 | 7.18 | 8.54 | 6.75 |
| 5-year avg ROE %i | 0.28 | -0.14 | -1.23 | 8.30 | 7.48 | 6.53 | 7.50 | 7.67 |
| EBIT margin %i | 13.08 | 7.73 | 12.75 | 6.56 | 10.21 | 15.08 | 16.58 | 14.87 |
| FCF / sales %i | 6.35 | 4.55 | 7.51 | 4.38 | 5.57 | 10.86 | 14.16 | 14.59 |
| Current ratioi | 1.58 | 2.13 | 2.03 | 2.04 | 1.91 | 1.73 | 1.85 | 2.00 |
| Quick ratioi | 0.77 | 1.04 | 1.22 | 1.25 | 1.00 | 0.96 | 1.05 | 1.20 |
| Debt / assetsi | 9.11 | 21.75 | 22.16 | 19.07 | 16.79 | 17.26 | 21.36 | 22.93 |
| LT debt / equityi | 14.92 | 36.45 | 33.87 | 29.16 | 25.99 | 27.53 | 28.65 | 38.90 |
| Interest coveragei | 12.86 | 4.46 | 5.48 | 3.31 | 5.68 | 9.08 | 7.46 | 7.09 |
| Revenue CAGR (3Y) %i | -2.60 | -5.27 | -9.03 | -6.01 | -0.24 | 2.65 | 1.19 | -2.35 |
| Net income CAGR (3Y) %i | -10.60 | -- | -6.68 | -32.98 | -2.86 | 4.63 | 34.85 | 11.45 |
| FCF CAGR (3Y) %i | -- | 2.17 | 56.92 | -16.96 | 6.73 | 16.09 | 49.68 | 34.61 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.03 | 8.76 | 10.83 | 11.94 | 8.72 | 9.20 |
| ROA %i | 5.38 | 5.14 | 6.37 | 6.82 | 5.02 | 5.06 |
| ROIC %i | 7.18 | 7.31 | 8.54 | 8.82 | 6.75 | 6.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.08 | 15.16 | 16.58 | 16.96 | 14.87 | 14.58 |
| FCF / sales %i | 10.86 | 13.13 | 14.16 | 17.50 | 14.59 | 17.94 |
| Current ratioi | 1.73 | 1.78 | 1.85 | 2.31 | 2.00 | 2.00 |
| Quick ratioi | 0.96 | 1.00 | 1.05 | 1.33 | 1.20 | 1.19 |
| Debt / assetsi | 17.26 | 24.04 | 21.36 | 23.90 | 22.93 | 27.57 |
| LT debt / equityi | 27.53 | 34.25 | 28.65 | 39.73 | 38.90 | 50.46 |
| Interest coveragei | 9.08 | 7.80 | 7.46 | 7.37 | 7.09 | 6.16 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Assessment & Qualifications is the largest reported line at 44.84% of revenue, across 5 reported segments.
- No single line clears half of revenue; Higher education is next at 21.67%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Assessment & Qualifications44.84%
Higher education21.67%
Virtual Learning14.29%
English Language Learning11.32%
Enterprise Learning & Skills7.88%
Region
US67.10%
UK14.26%
Asia Pacific9.90%
Other European Countries3.52%
Other countries3.33%
Canada1.90%
Quote time 2026-10-08 08:06:12 · For reference only, not investment advice and not tailored to your situation.